Cite
HARVARD Citation
Huang, A. et al. (2018). Direct‐acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local‐regional therapy or liver transplant waitlist dropout. Hepatology. 68 (2), pp. 449-461. [Online].